Flixotide Diskus 100 mcg
Reduces inflammation in the airways to prevent breathing difficulties and persistent symptoms associated with respiratory conditions.
GlaxoSmithKline is a multinational pharmaceutical and biotechnology company headquartered in the United Kingdom. Its operations span the discovery, development, and manufacturing of branded and generic medications across various fields of medicine. Two of their respiratory formulations are currently listed here for access by patients and healthcare professionals globally.
Reduces inflammation in the airways to prevent breathing difficulties and persistent symptoms associated with respiratory conditions.
Reduces inflammation in the airways to improve airflow and prevent symptoms like wheezing, tightness, and coughing.
GlaxoSmithKline, often referred to as GSK, is one of the world’s largest pharmaceutical companies, operating with a focus on immunology, oncology, global health, and respiratory disease. It functions as a research-based organization that maintains extensive manufacturing and distribution capabilities to support patients across North America, Europe, Australia, and other global markets.
The company’s role in the pharmaceutical industry involves the management of a diverse portfolio of treatments. While recognized for its contributions to vaccine development and specialty medicines, the company also engages in the production of established medications for chronic conditions. Their focus on respiratory care is a significant component of their therapeutic output, providing treatments for conditions such as asthma and chronic obstructive pulmonary disease.
The current selection of products highlights the company’s specialization in respiratory health. Specifically, the catalog includes maintenance inhalers such as Flixotide Diskus, which is prescribed for the long-term management of asthma. These formulations represent a portion of the broader range of inhalers and respiratory therapies developed under the GSK brand.
By focusing on inhalation technology, these products provide targeted delivery of medication to the lungs. The availability of different strengths, such as the 100 mcg and 250 mcg variants, allows healthcare providers to tailor treatments based on individual patient requirements and clinical assessments of respiratory function.
These products are pharmaceutical formulations manufactured by GlaxoSmithKline. Individual products differ in active ingredient, formulation, delivery method, and intended usage. This page functions as a catalog and does not provide clinical guidance or medical advice. Readers should review all provided product labeling and consult a healthcare professional regarding the suitability of any medication for their specific health needs.